These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 12062595)

  • 1. Hypothyroidism in children with medulloblastoma: a comparison of 3600 and 2340 cGy craniospinal radiotherapy.
    Paulino AC
    Int J Radiat Oncol Biol Phys; 2002 Jul; 53(3):543-7. PubMed ID: 12062595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy.
    Packer RJ; Sutton LN; Elterman R; Lange B; Goldwein J; Nicholson HS; Mulne L; Boyett J; D'Angio G; Wechsler-Jentzsch K
    J Neurosurg; 1994 Nov; 81(5):690-8. PubMed ID: 7931615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pilot study of preirradiation chemotherapy and 1800 cGy craniospinal irradiation in young children with medulloblastoma.
    Jakacki RI; Feldman H; Jamison C; Boaz JC; Luerssen TG; Timmerman R
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):531-6. PubMed ID: 15380589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyroid-stimulating hormone suppression for protection against hypothyroidism due to craniospinal irradiation for childhood medulloblastoma/primitive neuroectodermal tumor.
    Massimino M; Gandola L; Collini P; Seregni E; Marchianò A; Serra A; Pignoli E; Spreafico F; Pallotti F; Terenziani M; Biassoni V; Bombardieri E; Fossati-Bellani F
    Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):404-10. PubMed ID: 17601681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyroid dysfunction as a late effect in childhood medulloblastoma: a comparison of hyperfractionated versus conventionally fractionated craniospinal radiotherapy.
    Ricardi U; Corrias A; Einaudi S; Genitori L; Sandri A; di Montezemolo LC; Besenzon L; Madon E; Urgesi A
    Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1287-94. PubMed ID: 11483340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Updated results of a pilot study of low dose craniospinal irradiation plus chemotherapy for children under five with cerebellar primitive neuroectodermal tumors (medulloblastoma).
    Goldwein JW; Radcliffe J; Johnson J; Moshang T; Packer RJ; Sutton LN; Rorke LB; D'Angio GJ
    Int J Radiat Oncol Biol Phys; 1996 Mar; 34(4):899-904. PubMed ID: 8598368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Necrosis after craniospinal irradiation: results from a prospective series of children with central nervous system embryonal tumors.
    Murphy ES; Merchant TE; Wu S; Xiong X; Lukose R; Wright KD; Qaddoumi I; Armstrong GT; Broniscer A; Gajjar A
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):e655-60. PubMed ID: 22768993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The change in patterns of relapse in medulloblastoma.
    Tarbell NJ; Loeffler JS; Silver B; Lynch E; Lavally BL; Kupsky WJ; Scott RM; Sallan SE
    Cancer; 1991 Oct; 68(7):1600-4. PubMed ID: 1893359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A population-based study of thyroid function after radiotherapy and chemotherapy for a childhood brain tumor.
    Schmiegelow M; Feldt-Rasmussen U; Rasmussen AK; Poulsen HS; Müller J
    J Clin Endocrinol Metab; 2003 Jan; 88(1):136-40. PubMed ID: 12519842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of pediatric average-risk medulloblastoma using craniospinal irradiation less than 2500 cGy and chemotherapy: single center experience in Korea.
    Yoon JH; Park KD; Kang HJ; Kim H; Lee JW; Kim SK; Wang KC; Park SH; Kim IH; Shin HY
    World J Pediatr; 2017 Aug; 13(4):367-373. PubMed ID: 28550392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multi-institution prospective trial of reduced-dose craniospinal irradiation (23.4 Gy) followed by conformal posterior fossa (36 Gy) and primary site irradiation (55.8 Gy) and dose-intensive chemotherapy for average-risk medulloblastoma.
    Merchant TE; Kun LE; Krasin MJ; Wallace D; Chintagumpala MM; Woo SY; Ashley DM; Sexton M; Kellie SJ; Ahern V; Gajjar A
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):782-7. PubMed ID: 17892918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of hypothyroidism, growth hormone deficiency, and adrenal insufficiency following proton and photon radiotherapy in children with medulloblastoma.
    Aldrich KD; Horne VE; Bielamowicz K; Sonabend RY; Scheurer ME; Paulino AC; Mahajan A; Chintagumpala M; Okcu MF; Brown AL
    J Neurooncol; 2021 Oct; 155(1):93-100. PubMed ID: 34596831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of failure in children with medulloblastoma: effects of preirradiation chemotherapy.
    Hartsell WF; Gajjar A; Heideman RL; Langston JA; Sanford RA; Walter A; Jones D; Chen G; Kun LE
    Int J Radiat Oncol Biol Phys; 1997 Aug; 39(1):15-24. PubMed ID: 9300735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival and secondary tumors in children with medulloblastoma receiving radiotherapy and adjuvant chemotherapy: results of Children's Oncology Group trial A9961.
    Packer RJ; Zhou T; Holmes E; Vezina G; Gajjar A
    Neuro Oncol; 2013 Jan; 15(1):97-103. PubMed ID: 23099653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disease control and ototoxicity using intensity-modulated radiation therapy tumor-bed boost for medulloblastoma.
    Polkinghorn WR; Dunkel IJ; Souweidane MM; Khakoo Y; Lyden DC; Gilheeney SW; Becher OJ; Budnick AS; Wolden SL
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):e15-20. PubMed ID: 21481547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late toxicity following craniospinal radiation for early-stage medulloblastoma.
    Christopherson KM; Rotondo RL; Bradley JA; Pincus DW; Wynn TT; Fort JA; Morris CG; Mendenhall NP; Marcus RB; Indelicato DJ
    Acta Oncol; 2014 Apr; 53(4):471-80. PubMed ID: 24564687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of the German prospective randomized trial HIT '91.
    Kortmann RD; Kühl J; Timmermann B; Mittler U; Urban C; Budach V; Richter E; Willich N; Flentje M; Berthold F; Slavc I; Wolff J; Meisner C; Wiestler O; Sörensen N; Warmuth-Metz M; Bamberg M
    Int J Radiat Oncol Biol Phys; 2000 Jan; 46(2):269-79. PubMed ID: 10661332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preliminary results of conformal radiation therapy for medulloblastoma.
    Merchant TE; Happersett L; Finlay JL; Leibel SA
    Neuro Oncol; 1999 Jul; 1(3):177-87. PubMed ID: 11550312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyroid diseases in patients treated during pre-puberty for medulloblastoma with different radiotherapic protocols.
    Corrias A; Einaudi S; Ricardi U; Sandri A; Besenzon L; Altare F; Artesani L; Genitori L; Andreo M; De Sanctis C
    J Endocrinol Invest; 2001 Jun; 24(6):387-92. PubMed ID: 11434661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose craniospinal radiation therapy for medulloblastoma.
    Halberg FE; Wara WM; Fippin LF; Edwards MS; Levin VA; Davis RL; Prados MB; Wilson CB
    Int J Radiat Oncol Biol Phys; 1991 Apr; 20(4):651-4. PubMed ID: 2004939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.